Point72 Asset Management, L.P. 13D and 13G filings for AnaptysBio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-18 4:36 pm Purchase |
2025-02-14 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 1,691,372 5.600% |
902,827 (+114.49%) |
Filing |
| 2024-02-14 10:01 am Sale |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 788,545 3.000% |
-1,335,655 (-62.88%) |
Filing |
| 2023-02-14 4:21 pm Sale |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 2,124,200 7.500% |
-157,000 (-6.88%) |
Filing |
| 2022-09-09 4:54 pm Purchase |
2022-08-30 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 2,281,200 8.100% |
2,009,971 (+741.06%) |
Filing |
| 2022-02-14 4:38 pm Sale |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 271,229 1.000% |
-1,106,713 (-80.32%) |
Filing |
| 2021-01-13 5:06 pm Purchase |
2021-01-04 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 1,377,942 5.000% |
1,377,942 (New Position) |
Filing |